Valo Therapeutics
The company develops immunotherapies for cancer and infectious diseases using a platform that combines oncolytic and non-replicating vectors with disease-specific peptides. Its PeptiCRAd technology creates a specific and adaptable treatment designed to trigger immune responses in patients. The platform is intended to transform treatment and prevention protocols within the oncology sector.
Healthtech
Oncology
Infectious Disease
Biotechnology
Funding summary
- Total raised
- €33.3M
- Funding rounds
- 4
Investors in Valo Therapeutics
Investors on record for Valo Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Valo Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors